Target intelligence / Profile preview

Calcium release-activated calcium channel complex (CRAC channel)

Target
CRAC channel
Molecular classification
Ion channel, Calcium channel, Intracellular calcium sensor
01

Overview

The Calcium Release-Activated Calcium (CRAC) channel complex, composed of the ER-resident calcium sensor STIM1 and the plasma membrane pore-forming subunit Orai1, is the primary mediator of store-operated calcium entry (SOCE) (Prakriya & Lewis, 2015, Physiol Rev). When calcium levels within the endoplasmic reticulum (ER) drop, the N-terminal luminal EF-hand domain of STIM1 dissociates from calcium, triggering a conformational change that leads to STIM1 oligomerization and translocation to ER-plasma membrane junctions (Stathopulos et al., 2008, JBC). At these junctions, STIM1 physically interacts with and activates Orai1 channels, allowing a sustained influx of extracellular calcium into the cytoplasm. This signaling pathway is essential for maintaining intracellular calcium homeostasis and driving downstream processes such as the activation of the NFAT transcription factor, which is critical for T-cell function and the immune response (Feske et al., 2006, Nature). Dysregulation of the STIM-Orai pathway is implicated in various pathologies, including severe combined immunodeficiency, autoimmune disorders, and several types of cancer where it promotes cell migration and proliferation. Consequently, the CRAC channel has emerged as a significant therapeutic target, with several small-molecule inhibitors currently in clinical trials for conditions like acute pancreatitis and plaque psoriasis (CalciMedica, 2024; Rhizen Pharmaceuticals, 2023).

Other names
STIM-ORAI complexStore-operated calcium channelSOCE complexSOC channelSTIM1-Orai1 complex
02

Mechanism of action

Inhibition of Orai1-mediated calcium conductance or disruption of the STIM1-Orai1 interaction to prevent store-operated calcium entry (SOCE).

03

Biological functions

Calcium signalingImmune responseSignal transductionGene expressionCell proliferationMuscle contraction
04

Disease associations

Severe combined immunodeficiencyAutoimmune diseaseCancerAcute pancreatitisMyopathyPlaque psoriasis
05

Safety considerations

ImmunosuppressionSkeletal muscle weaknessAnhidrosis (lack of sweating)Impaired wound healingPotential for dental enamel defects
06

Interacting drugs

Auxora (CM4620)

5 more in the full profile.

07

Biomarkers

STIM1 protein expressionOrai1 protein expressionNFAT nuclear translocationIntracellular calcium oscillation patternsIL-2 production levels

Beyond the preview

Go deeper on Calcium release-activated calcium channel complex (CRAC channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium release-activated calcium channel complex (CRAC channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call